Advertisement
Advertisement
LFMD
LifeMD, Inc. Common Stock
2.37
USDSponsored
+0.08
+3.49%
Nov 06, 14:24 UTC -5
Closed
After-Market
2.38
0.00
+0.21%
LifeMD, Inc. Common Stock (LFMD) Earnings
LFMD Earnings Reports
Positive Surprise Ratio
LFMD beat 8 of 23 last estimates.
35%
Next Report
Tomorrow BMO
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
$49.86M
/-$0.14
Implied change from Q2 26 (Revenue/ EPS)
+5.46%
/-12.50%
Implied change from Q3 25 (Revenue/ EPS)
-17.13%
/+100.00%
LifeMD, Inc. Common Stock earnings per share and revenue
On Aug 05, 2026, LFMD reported earnings of -0.16 USD per share (EPS) for Q2 26, missing the estimate of -0.14 USD, resulting in a -7.67% surprise. Revenue reached 47.28 million, compared to an expected 50.08 million, with a -5.60% difference. The market reacted with a -7.61% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 9 analysts forecast an EPS of -0.14 USD, with revenue projected to reach 49.86 million USD, implying an decrease of -12.50% EPS, and increase of 5.46% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Sonida Senior Living, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.54
Actual
-$0.65
Surprise
-19.11%

Nutex Health Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$5.82
Actual
$5.71
Surprise
-1.93%

Omada Health, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.01
Actual
$0.17
Surprise
+900.00%

CryoPort, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.25
Surprise
-38.97%

Shoulder Innovations, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.50
Actual
-$0.34
Surprise
+32.57%

Biodesix, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.76
Actual
-$0.75
Surprise
+1.77%

SkinHealth Systems Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.30
Actual
-$0.14
Surprise
+89.28%

Natera, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.29
Actual
-$0.39
Surprise
-30.65%

Viatris Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.64
Actual
$0.71
Surprise
+9.31%

Solventum Corporation
Report Date
Nov 05, 2026 For Q3 26
Estimate
$1.38
Actual
$1.45
Surprise
+5.02%
FAQ
What were LifeMD, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, LifeMD, Inc. Common Stock reported EPS of -$0.16, missing estimates by -7.67%, and revenue of $47.28M, -5.6% below expectations.
How did the market react to LifeMD, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -7.61%, changed from $3.68 before the earnings release to $3.40 the day after.
When is LifeMD, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for LifeMD, Inc. Common Stock's next earnings report?
Based on 9
analysts, LifeMD, Inc. Common Stock is expected to report EPS of -$0.14 and revenue of $49.86M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.